Patent · US Active

Low intensity light therapy for treatment of retinal, macular, and visual pathway disorders

US9192780B2 · kind B2 · utility

50Cited by
173References
23Claims
0Family size

Assignee

Inventor

Key dates

Filing dateFeb 3, 2006
Grant dateNov 24, 2015
Priority date
Expiry dateFeb 27, 2027

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61N2005/0662
  • WIPO fieldMedical technology
  • WIPO sectorInstruments

Abstract

Disclosed is a system and method for treatment of cells and, in particular, visual pathway disorders. More particularly, the disclosed invention is directed toward the photomodulation and/or photorejuvenation of retinal epithelial cells, to treat a variety of vision disorders. The process of treating retinal cells to reduce or reverse the effects of visual pathway disorders employs a narrowband source of multichromatic light applied to the retinal cells to deliver a very low energy fluence.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.